Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENND1A antisense RNA 1 (DENND1A-AS1) is a long non-coding RNA gene, transcribed antisense relative to the DENND1A gene. Unlike the protein-coding DENND1A (which is a guanine nucleotide exchange factor involved in endocytosis and associated with steroidogenesis and polycystic ovary syndrome), DENND1A-AS1 does not encode a protein and is not a known direct drug target. There is limited published information about the molecular or disease functions, interacting drugs, or biomarker utility for DENND1A-AS1. Most associations between DENND1A and disease (especially PCOS) relate to the coding DENND1A gene or its splice variants, not the antisense RNA transcript[1][2][3][5][7]. If you seek information on the well-studied *protein-coding* DENND1A gene (connecdenn 1), that is a distinct entity with specific roles in membrane trafficking and PCOS pathophysiology[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENND1A antisense RNA 1 (DENND1A-AS1).